Clinical Medicine
Listando 37 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions
203
Twitter
0
Wikipedia
50
News
0
Policy
Article
Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies
Prat, Aleix; Chaudhury, Anwesha; Solovieff, Nadia; Pare, Laia; Martinez, Debora; Chic, Nuria; Martinez-Saez, Olga; Braso-Maristany, Fara; Lteif, Agnes; Taran, Tetiana; Babbar, Naveen; Su, Fei
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2021)
DOI /
10.1200/jco.20.02977
Gold other
Mentions
48
Twitter
0
Wikipedia
60
News
0
Policy
Article
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial
Llombart-Cussac, Antonio; Cortes, Javier; Pare, Laia; Galvan, Patricia; Bermejo, Begona; Martinez, Noelia; Vidal, Maria; Pernas, Sonia; Lopez, Rafael; Munoz, Montserrat; Nuciforo, Paolo; Morales, Serafin; Oliveira, Mafalda; de la Pena, Lorena; Pelaez, Alex
LANCET ONCOLOGY
1470-2045 (2017)
DOI /
10.1016/s1470-2045(17)30021-9
Mentions
73
Twitter
0
Wikipedia
37
News
0
Policy
Article
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade
Nuciforo, P.; Pascual, T.; Cortes, J.; Llombart-Cussac, A.; Fasani, R.; Pare, L.; Oliveira, M.; Galvan, P.; Martinez, N.; Bermejo, B.; Vidal, M.; Pernas, S.; Lopez, R.; Munoz, M.; Garau, I.; Manso, L.; Alarcon, J.; Martinez, E.; Rodrik-Outmezguine, V.; Bra
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdx647
Bronze
Mentions
193
Twitter
0
Wikipedia
9
News
0
Policy
Article
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Prat, Aleix; Saura, Cristina; Pascual, Tomas; Hernando, Cristina; Munoz, Montserrat; Pare, Laia; Gonzalez Farre, Blanca; Fernandez, Pedro L.; Galvan, Patricia; Chic, Nuria; Gonzalez Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Arumi, Miriam; Ferrer,
LANCET ONCOLOGY
1470-2045 (2020)
DOI /
10.1016/s1470-2045(19)30786-7
Mentions
192
Twitter
0
Wikipedia
9
News
0
Policy
Article
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
Schettini, Francesco; Chic, Nuria; Braso-Maristany, Fara; Pare, Laia; Pascual, Tomas; Conte, Benedetta; Martinez-Saez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernandez-Martinez, Aranzazu; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Ju
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-020-00208-2
Green published, Gold
Mentions
231
Twitter
0
Wikipedia
0
News
0
Policy
Article
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
Ciruelos, Eva; Villagrasa, Patricia; Pascual, Tomas; Oliveira, Mafalda; Pernas, Sonia; Pare, Laia; Escriva-de-Romani, Santiago; Manso, Luis; Adamo, Barbara; Martinez, Eduardo; Cortes, Javier; Vazquez, Silvia; Perello, Antonia; Garau, Isabel; Mele, Mireia;
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-0844
Mentions
50
Twitter
0
Wikipedia
5
News
0
Policy
Article
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Prat, Aleix; Pascual, Tomas; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortes, Javier; Rexer, Brent; Pare, Laia; Forero, Andres; Wolff, Antonio C.; Morales, Serafin; Adamo, Barbara; Braso-Maristany, Fara; Vidal, Maria;
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
0027-8874 (2020)
DOI /
10.1093/jnci/djz042
Green published, Bronze
Mentions
125
Twitter
0
Wikipedia
0
News
0
Policy
Article
Gene expression profiles of breast cancer metastasis according to organ site
Braso-Maristany, Fara; Pare, Laia; Chic, Nuria; Martinez-Saez, Olga; Pascual, Tomas; Mallafre-Larrosa, Meritxell; Schettini, Francesco; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Martinez, Debora; Galvan, Patricia; Barnadas, Esther; Salinas, Belinda; Tolosa
MOLECULAR ONCOLOGY
1574-7891 (2021)
DOI /
10.1002/1878-0261.13021
Gold DOAJ
Mentions
73
Twitter
0
Wikipedia
2
News
0
Policy
Article
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
Prat, Aleix; Navarro, Alejandro; Pare, Laia; Reguart, Noemi; Galvan, Patricia; Pascual, Tomas; Martinez, Alex; Nuciforo, Paolo; Comerma, Laura; Alos, Llucia; Pardo, Nuria; Cedres, Susana; Fan, Cheng; Parker, Joel S.; Gaba, Lydia; Victoria, Ivan; Vinolas, N
CANCER RESEARCH
0008-5472 (2017)
DOI /
10.1158/0008-5472.can-16-3556
Bronze
Mentions
10
Twitter
0
Wikipedia
6
News
0
Policy
Article
Chromosome 12p Amplification in Triple-Negative/BRCA1-Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity
Gomez-Miragaya, Jorge; Diaz-Navarro, Ander; Tonda, Raul; Beltran, Sergi; Palomero, Luis; Palafox, Marta; Dobrolecki, Lacey E.; Huang, Chen; Vasaikar, Suhas; Zhang, Bing; Wulf, Gerburg M.; Collado-Sole, Alejandro; Trinidad, Eva M.; Munoz, Purificacion; Pare
CANCER RESEARCH
0008-5472 (2019)
DOI /
10.1158/0008-5472.can-18-3835
Bronze
Mentions
55
Twitter
0
Wikipedia
2
News
0
Policy
Article
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Pare, L.; Pascual, T.; Segui, E.; Teixido, C.; Gonzalez-Cao, M.; Galvan, P.; Rodriguez, A.; Gonzalez, B.; Cuatrecasas, M.; Pineda, E.; Torne, A.; Crespo, G.; Martin-Algarra, S.; Perez-Ruiz, E.; Reig, O.; Viladot, M.; Font, C.; Adamo, B.; Vidal, M.; Gaba, L
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdy335
Bronze
Mentions
85
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
Braso-Maristany, Fara; Griguolo, Gaia; Pascual, Tomas; Pare, Laia; Nuciforo, Paolo; Llombart-Cussac, Antonio; Bermejo, Begona; Oliveira, Mafalda; Morales, Serafin; Martinez, Noelia; Vidal, Maria; Adamo, Barbara; Martinez, Olga; Pernas, Sonia; Lopez, Rafael
NATURE COMMUNICATIONS
(2020)
DOI /
10.1038/s41467-019-14111-3
Gold DOAJ, Green published
Mentions
31
Twitter
0
Wikipedia
3
News
0
Policy
Article
The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models
Gomez-Miragaya, Jorge; Moran, Sebastian; Erendira Calleja-Cervantes, Maria; Collado-Sole, Alejandro; Pare, Laia; Gomez, Antonio; Serra, Violeta; Dobrolecki, Lacey E.; Lewis, Michael T.; Diaz-Lagares, Angel; Eroles, Pilar; Prat, Aleix; Esteller, Manel; Gonz
MOLECULAR CANCER RESEARCH
1541-7786 (2019)
DOI /
10.1158/1541-7786.mcr-19-0040
Bronze, Green accepted
Mentions
73
Twitter
0
Wikipedia
1
News
0
Policy
Article
A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast Cancer
Prat, Aleix; Tsai, Yi-Hsuan; Pascual, Tomas; Pare, Laia; Adamo, Barbara; Vidal, Maria; Braso-Maristany, Fara; Galvan, Patricia; Brase, Jan Christoph; Rodrik-Outmezguine, Vanessa; Johnston, Stephen; Ciruelos, Eva; Parker, Joel S.
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-2793
Mentions
87
Twitter
0
Wikipedia
0
News
0
Policy
Article
ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
Griguolo, Gaia; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pascual, Tomas; Chic, Nuria; Sauri, Tamara; Kates, Ronald; Gluz, Oleg; Martinez, Debora; Pare, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Galv
CANCERS
(2020)
DOI /
10.3390/cancers12071902
Gold DOAJ, Green published
Mentions
27
Twitter
0
Wikipedia
2
News
0
Policy
Article
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer
Cejalvo, Juan M.; de Duenas, Eduardo Martinez; Galvan, Patricia; Garcia-Recio, Susana; Gasion, Octavio Burgues; Pare, Laia; Antolin, Silvia; Martinello, Rosella; Blancas, Isabel; Adamo, Barbara; Guerrero-Zotano, Angel; Munoz, Montserrat; Nuciforow, Paolo;
CANCER RESEARCH
0008-5472 (2017)
DOI /
10.1158/0008-5472.can-16-2717
Bronze, Green accepted
Mentions
66
Twitter
0
Wikipedia
0
News
0
Policy
Article
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2(+) Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype
Guarneri, Valentina; Dieci, Maria Vittoria; Bisagni, Giancarlo; Brandes, Alba A.; Frassoldati, Antonio; Cavanna, Luigi; Musolino, Antonino; Giotta, Francesco; Rimanti, Anita; Garrone, Ornella; Bertone, Elena; Cagossi, Katia; Nanni, Oriana; Piacentini, Fede
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-1731
Bronze, Green published
Mentions
55
Twitter
0
Wikipedia
0
News
0
Policy
Article
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial
Adamo, Barbara; Bellet, Meritxell; Pare, Laia; Pascual, Tomas; Vidal, Maria; Perez Fidalgo, Jose A.; Blanch, Salvador; Martinez, Noelia; Murillo, Laura; Gomez-Pardo, Patricia; Lopez-Gonzalez, Ana; Amillano, Kepa; Canes, Jordi; Galvan, Patricia; Gonzalez-Fa
BREAST CANCER RESEARCH
1465-542X (2019)
DOI /
10.1186/s13058-019-1195-z
Gold DOAJ, Green published
Mentions
61
Twitter
0
Wikipedia
0
News
0
Policy
Article
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer
Pascual, Tomas; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavila, Joaquin; Pernas, Sonia; Munoz, Montserrat; Vidal, Maria J.; Margeli Vila, Mireia; Cejalvo, Juan M.; Gonzalez-Farre, Blanca; Espinosa-Bravo, Martin; Cruz,
FRONTIERS IN ONCOLOGY
2234-943X (2021)
DOI /
10.3389/fonc.2021.638482
Gold DOAJ, Green published
Mentions
51
Twitter
0
Wikipedia
0
News
0
Policy
Article
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy
Pascual, Tomas; Fernandez-Martinez, Aranzazu; Tanioka, Maki; Dieci, M. Vittoria; Pernas, Sonia; Gavila, Joaquin; Guarnieri, Valentina; Cortes, Javier; Villagrasa, Patricia; Chic, Nuria; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Griguolo, Gaia; Llomb
CLINICAL CANCER RESEARCH
1078-0432 (2021)
DOI /
10.1158/1078-0432.ccr-20-4102
Bronze
Mentions
39
Twitter
0
Wikipedia
0
News
0
Policy
Article
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
Gavila, Joaquin; Oliveira, Mafalda; Pascual, Tomas; Perez-Garcia, Jose; Gonzalez, Xavier; Canes, Jordi; Pare, Laia; Calvo, Isabel; Ciruelos, Eva; Munoz, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andres, Raquel; Perello, Antonia; Martinez, Jeronimo; Mor
BMC MEDICINE
1741-7015 (2019)
DOI /
10.1186/s12916-018-1233-1
Green published, Gold
Mentions
41
Twitter
0
Wikipedia
0
News
0
Policy
Article
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
Pascual, Tomas; Oliveira, Mafalda; Villagrasa, Patricia; Ortega, Vanesa; Pare, Laia; Bermejo, Begona; Morales, Serafin; Amillano, Kepa; Lopez, Rafael; Galvan, Patricia; Canes, Jordi; Salvador, Fernando; Nuciforo, Paolo; Rubio, Isabel T.; Llombart-Cussac, A
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00351-4
Gold
Mentions
44
Twitter
0
Wikipedia
0
News
0
Policy
Article
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Pascual, Tomas; Martin, Miguel; Fernandez-Martinez, Aranzazu; Pare, Laia; Alba, Emilio; Rodriguez-Lescure, Alvaro; Perrone, Giuseppe; Cortes, Javier; Morales, Serafin; Lluch, Ana; Urruticoechea, Ander; Gonzalez-Farre, Blanca; Galvan, Patricia; Jares, Pedro
FRONTIERS IN ONCOLOGY
2234-943X (2019)
DOI /
10.3389/fonc.2019.00303
Gold DOAJ, Green published
Mentions
36
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
Griguolo, G.; Serna, G.; Pascual, T.; Fasani, R.; Guardia, X.; Chic, N.; Pare, L.; Pernas, S.; Munoz, M.; Oliveira, M.; Vidal, M.; Llombart-Cussac, A.; Cortes, J.; Galvan, P.; Bermejo, B.; Martinez, N.; Lopez, R.; Morales, S.; Garau, I; Manso, L.; Alarcon,
NPJ PRECISION ONCOLOGY
(2021)
DOI /
10.1038/s41698-021-00163-6
Gold DOAJ
Mentions
31
Twitter
0
Wikipedia
0
News
0
Policy
Article
De-escalated therapy for HR+/HER2+breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
Guarneri, V; Dieci, M., V; Bisagni, G.; Frassoldati, A.; Bianchi, G., V; De Salvo, G. L.; Orvieto, E.; Urso, L.; Pascual, T.; Pare, L.; Galvan, P.; Ambroggi, M.; Giorgi, C. A.; Moretti, G.; Griguolo, G.; Vicini, R.; Prat, A.; Conte, P. F.
ANNALS OF ONCOLOGY
0923-7534 (2019)
DOI /
10.1093/annonc/mdz055
Gold other, Green published
Mentions
33
Twitter
0
Wikipedia
0
News
0
Policy
Article
Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer
Schettini, F.; Barbao, P.; Braso-Maristany, F.; Galvan, P.; Martinez, D.; Pare, L.; De Placido, S.; Prat, A.; Guedan, S.
ESMO OPEN
(2021)
DOI /
10.1016/j.esmoop.2021.100102
Green published, Gold
Mentions
27
Twitter
0
Wikipedia
0
News
0
Policy
Article
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
De Mattos-Arruda, Leticia; Cortes, Javier; Blanco-Heredia, Juan; Tiezzi, Daniel G.; Villacampa, Guillermo; Goncalves-Ribeiro, Samuel; Pare, Laia; Souza, Carla Anjos; Ortega, Vanesa; Sammut, Stephen-John; Cusco, Pol; Fasani, Roberta; Chin, Suet-Feung; Perez
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00282-0
Green published, Gold
Mentions
20
Twitter
0
Wikipedia
0
News
0
Policy
Article
Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy
Floros, Konstantinos V.; Lochmann, Timothy L.; Hu, Bin; Monterrubio, Carles; Hughes, Mark T.; Wells, Jason D.; Bernado Morales, Cristina; Ghotra, Maninderjit S.; Costa, Carlotta; Souers, Andrew J.; Boikos, Sosipatros A.; Leverson, Joel D.; Tan, Ming; Serra
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
0027-8424 (2018)
DOI /
10.1073/pnas.1717820115
Gold other, Green published
Mentions
25
Twitter
0
Wikipedia
0
News
0
Policy
Article
Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2
Prat, Aleix; Christoph Brase, Jan; Cheng, Yuan; Nuciforo, Paolo; Pare, Laia; Pascual, Tomas; Martinez, Debora; Galvan, Patricia; Vidal, Maria; Adamo, Barbara; Hortobagyi, Gabriel N.; Baselga, Jose; Ciruelos, Eva
ONCOLOGIST
1083-7159 (2019)
DOI /
10.1634/theoncologist.2018-0407
Green published, Bronze
Mentions
20
Twitter
0
Wikipedia
0
News
0
Policy
Article
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial
Gluz, Oleg; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claud
INTERNATIONAL JOURNAL OF CANCER
0020-7136 (2020)
DOI /
10.1002/ijc.32488
Mentions
11
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Garrido-Castro, Ana C.; Saura, Cristina; Barroso-Sousa, Romualdo; Guo, Hao; Ciruelos, Eva; Bermejo, Begona; Gavila, Joaquin; Serra, Violeta; Prat, Aleix; Pare, Laia; Celiz, Pamela; Villagrasa, Patricia; Li, Yisheng; Savoie, Jennifer; Xu, Zhan; Arteaga, Car
BREAST CANCER RESEARCH
1465-542X (2020)
DOI /
10.1186/s13058-020-01354-y
Gold DOAJ, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients
Reguart, Noemi; Teixido, Cristina; Gimenez-Capitan, Ana; Pare, Laia; Galvan, Patricia; Viteri, Santiago; Rodriguez, Sonia; Peg, Vicente; Aldeguer, Erika; Vinolas, Nuria; Remon, Jordi; Karachaliou, Niki; Conde, Esther; Lopez-Rios, Fernando; Nadal, Ernest; M
CLINICAL CHEMISTRY
0009-9147 (2017)
DOI /
10.1373/clinchem.2016.265314
Bronze
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse
Prat, Aleix; Lluch, Ana; Turnbull, Arran K.; Dunbier, Anita K.; Calvo, Lourdes; Albanell, Joan; de la Haba-Rodriguez, Juan; Arcusa, Angels; Ignacio Chacon, Jose; Sanchez-Rovira, Pedro; Plazaola, Arrate; Munoz, Montserrat; Pare, Laia; Parker, Joel S.; Ribel
CLINICAL CANCER RESEARCH
1078-0432 (2017)
DOI /
10.1158/1078-0432.ccr-16-2092
Bronze, Green accepted, Green published
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Development and validation for research assessment of Oncotype DX (R) Breast Recurrence Score, EndoPredict (R) and Prosigna (R)
Buus, Richard; Szijgyarto, Zsolt; Schuster, Eugene F.; Xiao, Hui; Haynes, Ben P.; Sestak, Ivana; Cuzick, Jack; Pare, Laia; Segui, Elia; Chic, Nuria; Prat, Aleix; Dowsett, Mitch; Cheang, Maggie Chon U.
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00216-w
Gold DOAJ, Green published
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer
Quintana, Angela; Peg, Vicente; Prat, Aleix; Moline, Teresa; Villacampa, Guillermo; Pare, Laia; Galvan, Patricia; Dientsmann, Rodrigo; Schmid, Peter; Curigliano, Giuseppe; Munoz-Couselo, Eva; Perez-Garcia, Jose; Marti, Merce; Blanco-Heredia, Juan; Dos Anjo
EUROPEAN JOURNAL OF CANCER
0959-8049 (2021)
DOI /
10.1016/j.ejca.2021.01.037
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer
Griguolo, Gaia; Dieci, Maria Vittoria; Pare, Laia; Miglietta, Federica; Generali, Daniele Giulio; Frassoldati, Antonio; Cavanna, Luigi; Bisagni, Giancarlo; Piacentini, Federico; Tagliafico, Enrico; Cagossi, Katia; Ficarra, Guido; Prat, Aleix; Conte, Pierfr
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00223-x
Gold DOAJ, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer
Fernandez-Martinez, Aranzazu; Pascual, Tomas; Perrone, Giuseppe; Morales, Serafin; de la Haba, Juan; Gonzalez-Rivera, Milagros; Galvan, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucia; Prats, Miquel; Rojo, Federico; Manso, Luis; Pare, Laia; Alo
ONCOTARGET
1949-2553 (2017)
DOI /
10.18632/oncotarget.15748
Bronze, Green published
